Rosanne.Wouters Not Provided
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rosanne.Wouters Not Provided has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Igor Beletchi
KU Leuven
2 shared publicationsPeter Vangheluwe
KU Leuven
2 shared publications- Abril Escamilla-Ayala
KU Leuven
1 shared publication Bertrand Kleizen
Cellular Protein Chemistry, Bijvoet Center for Biomolecular Research, Faculty of Science, Utrecht University, Utrecht, The Netherlands 3
1 shared publicationChris Van Den Haute
KU Leuven
1 shared publication- Christine Michiels
Laboratory for Membrane Trafficking, Vlaams Instituut voor Biotechnologie Center for Brain and Disease Research, Katholieke Universiteit Leuven, Leuven, Belgium 1
1 shared publication
Latest Publications
- Open Access
- 1 June 2023
- Published by Springer Nature
immunofluorescent staining with anti-GFP and anti-CD63 antibodies v1
This protocol was used for immunofluorescent staining in fixed HeLa cells with anti-GFP and anti-CD63 antibodies, followed by confocal imaging.
- 1 June 2023
- Published by Springer Nature
Open Accessimmunofluorescent staining with anti-GFP and anti-CD63 antibodies v1
This protocol was used for immunofluorescent staining in fixed HeLa cells with anti-GFP and anti-CD63 antibodies, followed by confocal imaging.
- Open Access
- 1 June 2023
- Published by Springer Nature
Cell surface biotinylation v1
The protocol describes cell surface biotinylation to identify plasma membrane localized proteins in cell culture via western blotting.
- 1 June 2023
- Published by Springer Nature
Open AccessCell surface biotinylation v1
The protocol describes cell surface biotinylation to identify plasma membrane localized proteins in cell culture via western blotting.
- Open Access
The lipid flippase ATP10B enables cellular lipid uptake under stress conditions
Pathogenic ATP10B variants have been described in patients with Parkinson’s disease and dementia with Lewy body disease, and we previously established ATP10B as a late endo-/lysosomal lipid flippase transporting both phosphatidylcholine (PC) and glucosylceramide (GluCer) from the lysosomal exoplasmic to cytoplasmic membrane leaflet. Since several other lipid flippases regulate cellular lipid uptake, we here examined whether also ATP10B impacts cellular lipid uptake. Transient co-expression of ATP10B with its obligatory subunit CDC50A stimulated the uptake of fluorescently (NBD-) labeled PC in HeLa cells. This uptake is dependent on the transport function of ATP10B, is impaired by disease-associated variants and appears specific for NBD-PC. Uptake of non-ATP10B substrates, such as NBD-sphingomyelin or NBD-phosphatidylethanolamine is not increased. Remarkably, in stable cell lines co-expressing ATP10B/CDC50A we only observed increased NBD-PC uptake following treatment with rotenone, a mitochondrial complex I inhibitor that induces transport-dependent ATP10B phenotypes. Conversely, Im95m and WM-115 cells with endogenous ATP10B expression, present a decreased NBD-PC uptake following ATP10B knockdown, an effect that is exacerbated under rotenone stress. Our data show that the endo-/lysosomal lipid flippase ATP10B contributes to cellular PC uptake under specific cell stress conditions.
Open AccessThe lipid flippase ATP10B enables cellular lipid uptake under stress conditions
Pathogenic ATP10B variants have been described in patients with Parkinson’s disease and dementia with Lewy body disease, and we previously established ATP10B as a late endo-/lysosomal lipid flippase transporting both phosphatidylcholine (PC) and glucosylceramide (GluCer) from the lysosomal exoplasmic to cytoplasmic membrane leaflet. Since several other lipid flippases regulate cellular lipid uptake, we here examined whether also ATP10B impacts cellular lipid uptake. Transient co-expression of ATP10B with its obligatory subunit CDC50A stimulated the uptake of fluorescently (NBD-) labeled PC in HeLa cells. This uptake is dependent on the transport function of ATP10B, is impaired by disease-associated variants and appears specific for NBD-PC. Uptake of non-ATP10B substrates, such as NBD-sphingomyelin or NBD-phosphatidylethanolamine is not increased. Remarkably, in stable cell lines co-expressing ATP10B/CDC50A we only observed increased NBD-PC uptake following treatment with rotenone, a mitochondrial complex I inhibitor that induces transport-dependent ATP10B phenotypes. Conversely, Im95m and WM-115 cells with endogenous ATP10B expression, present a decreased NBD-PC uptake following ATP10B knockdown, an effect that is exacerbated under rotenone stress. Our data show that the endo-/lysosomal lipid flippase ATP10B contributes to cellular PC uptake under specific cell stress conditions.
- Open Access
- 31 May 2023
- Published by Springer Nature
Microsomal membrane isolation from cell culture v1
Microsomal membrane isolation from cell culture
- 31 May 2023
- Published by Springer Nature
Open AccessMicrosomal membrane isolation from cell culture v1
Microsomal membrane isolation from cell culture
- Open Access
- 31 May 2023
- Published by Springer Nature
Cellular lipid uptake with flow cytometry readout v1
Cellular lipid uptake with flow cytometry readout
- 31 May 2023
- Published by Springer Nature
Open AccessCellular lipid uptake with flow cytometry readout v1
Cellular lipid uptake with flow cytometry readout
- Open Access
- 22 July 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 220 (9)
Assembly of γ-secretase occurs through stable dimers after exit from the endoplasmic reticulum
γ-Secretase affects many physiological processes through targeting >100 substrates; malfunctioning links γ-secretase to cancer and Alzheimer’s disease. The spatiotemporal regulation of its stoichiometric assembly remains unresolved. Fractionation, biochemical assays, and imaging support prior formation of stable dimers in the ER, which, after ER exit, assemble into full complexes. In vitro ER budding shows that none of the subunits is required for the exit of others. However, knockout of any subunit leads to the accumulation of incomplete subcomplexes in COPII vesicles. Mutating a DPE motif in presenilin 1 (PSEN1) abrogates ER exit of PSEN1 and PEN-2 but not nicastrin. We explain this by the preferential sorting of PSEN1 and nicastrin through Sec24A and Sec24C/D, respectively, arguing against full assembly before ER exit. Thus, dimeric subcomplexes aided by Sec24 paralog selectivity support a stepwise assembly of γ-secretase, controlling final levels in post-Golgi compartments.
- 22 July 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 220 (9)
Open AccessAssembly of γ-secretase occurs through stable dimers after exit from the endoplasmic reticulum
γ-Secretase affects many physiological processes through targeting >100 substrates; malfunctioning links γ-secretase to cancer and Alzheimer’s disease. The spatiotemporal regulation of its stoichiometric assembly remains unresolved. Fractionation, biochemical assays, and imaging support prior formation of stable dimers in the ER, which, after ER exit, assemble into full complexes. In vitro ER budding shows that none of the subunits is required for the exit of others. However, knockout of any subunit leads to the accumulation of incomplete subcomplexes in COPII vesicles. Mutating a DPE motif in presenilin 1 (PSEN1) abrogates ER exit of PSEN1 and PEN-2 but not nicastrin. We explain this by the preferential sorting of PSEN1 and nicastrin through Sec24A and Sec24C/D, respectively, arguing against full assembly before ER exit. Thus, dimeric subcomplexes aided by Sec24 paralog selectivity support a stepwise assembly of γ-secretase, controlling final levels in post-Golgi compartments.